The Food and Drug Administration today alerted the public to growing concern about the potential for medical device shortages as facilities that sterilize devices using ethylene oxide close. “Since we first became aware of this issue earlier this year, we have continued to focus intently on addressing the immediate impacts of these closures and potential closures to help ensure patients can have access to the safe, effective, and high-quality medical devices they need today,” said Acting FDA Commissioner Ned Sharpless, M.D. “We continue to communicate directly with manufacturers and monitor the supply of devices sterilized in facilities that have closed or that may close, paying special attention to life-saving, life-sustaining, and other critical devices.” He urged health care providers and medical device makers to assess their supplies of affected devices and report anticipated shortages or distribution delays by email to deviceshortages@fda.hhs.gov.

Related News Articles

Headline
The Food and Drug Administration approved the second generic naloxone nasal spray, an emergency treatment for known or suspected opioid overdose. The…
Headline
The Department of Health and Human Services has launched a webpage to help health care providers and families locate infant formula during the current national…
Headline
President Biden yesterday invoked the Defense Production Act to ensure manufacturers have the necessary ingredients to make infant formula in the United States…
Headline
The House Energy and Commerce Health Subcommittee today passed, as amended, the Restoring Hope for Mental Health and Well-being Act (H.R. 7666),…
Headline
In a letter today, AHA asked GE Healthcare to provide additional information to help member hospitals manage the current shortage of GE intraveneous…
Headline
The House Energy and Commerce Health Subcommittee yesterday voted unanimously to advance to the full committee the Restoring Hope for Mental Health and Well-…